This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...